BMS-820132
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-820132, covering 2011-03-09 to 2012-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes [Phase 1]